936501-51-8 Usage
Description
(3-Benzyloxetan-3-yl)methanol is a compound with the chemical formula C11H12O2. It is a derivative of oxetane, which is a four-membered cyclic ether. (3-benzyloxetan-3-yl)methanol is known for its wide range of chemical reactivity and potential biological activities.
Uses
Used in Pharmaceutical Industry:
(3-Benzyloxetan-3-yl)methanol is used as a building block in organic synthesis for the preparation of pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, (3-benzyloxetan-3-yl)methanol serves as a key intermediate in the synthesis of various agrochemicals, contributing to the development of effective pest control solutions.
Used in Organic Synthesis:
(3-Benzyloxetan-3-yl)methanol is utilized as a starting material for the synthesis of a diverse array of organic compounds, thanks to its ability to participate in numerous chemical reactions.
Used in Antimicrobial Applications:
(3-Benzyloxetan-3-yl)methanol has been studied for its antimicrobial properties, making it a potential candidate for use in applications that require the inhibition of microbial growth.
Used in Antitumor Research:
(3-benzyloxetan-3-yl)methanol has also been investigated for its antitumor potential, indicating that it could be a promising agent in the fight against cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 936501-51-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,5,0 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 936501-51:
(8*9)+(7*3)+(6*6)+(5*5)+(4*0)+(3*1)+(2*5)+(1*1)=168
168 % 10 = 8
So 936501-51-8 is a valid CAS Registry Number.
936501-51-8Relevant articles and documents
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
-
Page/Page column 84; 85, (2013/10/22)
Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H- imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
